Cited by 103Alzheimer's disease research and treatmentsMemory and Neural MechanismsNeuroscience and Neuropharmacology Research

Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease

Open access
Rudinskiy, Nikita, Hawkes, Jonathan M, Betensky, Rebecca A, Eguchi, Megumi, Yamaguchi, Shun, Spires-Jones, Tara L, Hyman, Bradley T·2012·Nature Neuroscience

Abstract

Experience-induced expression of immediate-early gene Arc (also known as Arg3.1) is known to be important for consolidation of memory. Using in vivo longitudinal multiphoton imaging, we found orchestrated activity-dependent expression of Arc in the mouse extrastriate visual cortex in response to a structured visual stimulation. In wild-type mice, the amplitude of the Arc response in individual neurons strongly predicted the probability of reactivation by a subsequent presentation of the same stimulus. In a mouse model of Alzheimer's disease, this association was markedly disrupted in the cortex, specifically near senile plaques. Neurons in the vicinity of plaques were less likely to respond, but, paradoxically, there were stronger responses in those few neurons around plaques that did respond. To the extent that the orchestrated pattern of Arc expression reflects nervous system responses to and physiological consolidation of behavioral experience, the disruption in Arc patterns reveals plaque-associated interference with neural network integration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nn.3199

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Soluble oligomeric tau may play a more essential role in neurodegeneration than insoluble fibrillar tau, including NFTs.

    “These findings indicate that soluble oligomeric tau may play a more essential role in neurodegeneration than insoluble fibrillar tau (including NFT), the “tau we can see”.”
  • Soluble tau, rather than fibrillar tau, impacts responsiveness of neurons to environmental stimuli in hippocampus after memory formation.

    “From assessments of immediate early gene expression in the hippocampus after memory formation, it again appears that soluble tau, rather than fibrillar tau, seems to impact the responsiveness of neurons to environmental stimuli.”

    From All the Tau We Cannot See (2023) · cites this paper as [21]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 52 · Cited by 103

Authors
Rudinskiy, N., Hawkes, J. M., Betensky, R. A., Eguchi, M., Yamaguchi, S., Spires-Jones, T. L., & Hyman, B. T.
Affiliations
  • Harvard University (US)
  • Northeastern University (US)
  • Gifu University (JP)
Corresponding author
Hyman, Bradley T
Venue
Nature Neuroscience
Published
2012-08-26
Volume
15
Issue
10
Pages
1422-1429
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W1984881525
Cited by
103
References
52
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 6 · 2018: 7 · 2017: 11 · 2016: 10 · 2015: 9 · 2014: 11 · 2013: 9 · 2012: 1
FWCI
6.43
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders
National Institute on Aging (AG-08487, R01AG026249, R00AG033670, R01AG008487, AG033670, P50AG005134, K99AG033670, P30AG062421)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Arc/Arg3.1, Alzheimer's disease, immediate early genes, memory consolidation, amyloid plaques, amyloid-beta, extrastriate cortex, neural network integration, multiphoton imaging, mouse model
MeSH terms
Alzheimer Disease, Animals, Cytoskeletal Proteins, Disease Models, Animal, Mice, Transgenic, Nerve Tissue Proteins, Neurons, Photic Stimulation, Visual Cortex, Microscopy, Fluorescence, Multiphoton, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review